Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
IF ›
IFLENZEA
Trademark search for:
IFLENZEA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-07-21 — Application filed
2015-09-17 — Sn assigned for sect 66a appl from ib
2015-09-18 — Application filed
2015-09-22 — Application filed
2015-09-24 — Assigned to examiner
2015-09-28 — Approved for pub - principal register
2015-10-21 — Notice of publication
2015-11-04 — Notice of start of opposition period created, to be sent to ib
2015-11-04 — Notification of possible opposition sent to ib
2015-11-10 — Published for opposition
2015-11-15 — Change of owner received from ib
2015-11-20 — Notification processed by ib
2016-01-26 — Registered-principal register
2016-02-25 — Grant of protection created, to be sent to ib
2016-04-19 — Final disposition recorded
2016-04-19 — Final disposition recorded
2016-08-19 — Notification processed by ib
2016-09-29 — Teas revoke/app/change addr of atty/dom rep received
2016-09-29 — Attorney/dom.rep.revoked and/or appointed
2016-11-03 — Change of name/address rec'd from ib
2017-01-31 — Correspondence received in law office
2017-05-23 — Review of correspondence complete - address updated
2019-06-06 — New representative at ib received
2021-01-26 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2022-08-12 — Cancelled section 71
2022-08-12 — Final status recorded
2023-04-12 — Total invalidation of reg ext protection created
2023-05-24 — Invalidation processed
2023-05-24 — Total invalidation of reg ext protection sent to ib
2023-06-18 — Total invalidation processed by the ib
2024-01-05 — New representative at ib received
2025-01-03 — New representative at ib received
Owner Information
Seqirus UK Limited
GB
Seqirus UK Limited
GB
NOVARTIS AG
CH
NOVARTIS AG
CH
Correspondent
Nancy Sabarra Fross Zelnick Lehrman & Zissu, P.C. 4 TIMES SQUARE, 17TH FLOOR New York, NY 10036 UNITED STATES
Filing Details
Filing Date:
2015-07-21
Status Date:
2022-08-12
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.